|
|
Author: Vaibhav Sivaramakrishan
 |
Total Articles: 4 |
Total Views: 7022
City: Bangkok |
State: -
About Me: I am an undergraduate
biotechnology student and am
interested to work in the
field of Pharmaceutical
Regulatory Affairs. |
Articles by Vaibhav Sivaramakrishan:
-
Advances in Antihypertensive Medication
This report serves to explain the pharmacodynamics of antihypertensive drugs and also give an overview of the possibilities of the commercialization of vaccines for the same purpose.
- Category:
Healthcare
-
Orphan Drugs: A Small Market Segment With Hefty Perks
Orphan drugs are pharmaceuticals which are developed to treat rare diseases. The Food and Drug Administration (FDA) has several strategies to motivate pharmaceutical companies to produce such drugs. This article summarizes the incentives offered to orphan drug manufacturers.
- Category:
Healthcare
-
A Beginner's Guide to the Investigational New Drug Application
The Investigational New Drug (IND) Application is a document that proves to the Food and Drug Administration (FDA) that a new drug is safe enough for testing in human subjects. This article aims to give the reader a basic understanding of the IND application and it's importance in Pharmaceutical Regulatory Affairs.
- Category:
Healthcare
-
Sibutramine: Suppresses Your Appetite and Can Harm You!
Sibutramine is a neurotransmitter reuptake inhibitor and is used widely in the treatment of obesity. It has been used since 1997, but has recently found to be a major cause of heart disease. The Food and Drug Administration is currently reviewing the effects of the drug on the heart. This report intends to explain to the reader the pharmacodynamics of the drug and recent regulations on its sale.
- Category:
Healthcare
|
|
